Biogen Inc (BIIB)

167.00 +1.21 (+0.73%) USD  |  NASDAQ  |  Nov 14, 12:20
More

Biogen Non-Current Deferred Revenue (Quarterly)

Non-Current Deferred Revenue (Quarterly) Chart

View Non-Current Deferred Revenue (Quarterly) for BIIB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Non-Current Deferred Revenue (Quarterly) Data

View and export this data back to . Upgrade now.
Date Value

Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Deferred Revenue (Quarterly) Benchmarks

Eli Lilly and Co --
Sage Therapeutics Inc --
Ionis Pharmaceuticals Inc Upgrade
Pfizer Inc --
Repligen Corp --